Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced

AIMS: Anaemia is frequent among patients with heart failure (HF) and reduced ejection fraction (HFrEF) and is associated with poor outcomes. Sodium–glucose co‐transporter 2 inhibitors (SGLT2i) increase haematocrit and may correct anaemia. This study aims to investigate the impact of empagliflozin on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, João Pedro, Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos, Iwata, Tomoko, Salsali, Afshin, Zeller, Cordula, Pocock, Stuart J., Zannad, Faiez, Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Anaemia and Iron Deficiency
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303456/
https://www.ncbi.nlm.nih.gov/pubmed/34957660
http://dx.doi.org/10.1002/ejhf.2409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303456/
https://www.ncbi.nlm.nih.gov/pubmed/34957660
http://dx.doi.org/10.1002/ejhf.2409

Ejemplares similares